Novo Nordisk A/S
NVOEquityAI Summary
Updated 3h ago
Novo Nordisk A/S (NVO) is in a relatively unremarkable position right now
Novo Nordisk A/S (NVO) is in a relatively unremarkable position right now. Momentum, flow, and extension indicators are all sitting near the middle of their historical ranges — none are signalling anything unusual. For reference: Flow Score 25/100, Trend & Momentum Score 16/100.
Market Positioning
The Bigger Picture
Macro context will be updated shortly
Technical Analysis
Market Positioning
Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.
Key Levels
Looking at the full picture for Novo Nordisk A/S (NVO): extension is slightly below average (40th percentile), momentum is slightly below average (38th percentile), flow is slightly above average (55th percentile), volatility is below average (26th percentile).
Where is money flowing?
Trend
Is momentum building or fading?
What is the relative strength?
How extended is this move?
Where are the key levels?
What risk am I taking?
Conclusion
Novo Nordisk A/S (NVO) sits in a relatively neutral position across all four dimensions — there is no extreme reading demanding attention right now. There is not a strong signal here in either direction. This is an asset to watch rather than act on right now. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.
Your portfolio. Your context. Smarter decisions.
Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.
Personalized insights based on your actual holdings
Major market movements delivered to your inbox
Track the assets that matter most to you
No credit card required